CDK Global has successfully renewed its DMS agreement with Sonic Automotive, securing a key partnership following two ...

Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

The news reinforces CDK's reputation in the DMS business and, presumably, will help the company land more extensions and new ...

Roche RHHBY announced an asset purchase agreement with clinical-stage biotechnology company Regor Therapeutics. Per the ...

In Hybrids amidst financial challenges. Read More CDK Global extends DMS contract with Sonic Automotive amid cyberattack ...

Meanwhile, the acquisition of AntlerA, which Roche called a leader in Wnt signaling, gives the pharma ownership of a library ...

A federal judge in Illinois has granted preliminary approval to a settlement in which CDK Global agrees to pay $100 million ...

The contract extension with Sonic is a win for market leader CDK, which faced challenges over the summer after two ...

Roche is spending $850 million upfront to buy Regor Pharmaceuticals’ suite of next-generation CDK inhibitors as it doubles ...

It hasn’t been the best of years for CDK Global, but it got some good news Monday. Sonic Automotive, one of the nation’s ...

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

CDK, the leading automotive retail software provider, today announced the extension of its agreement with Sonic Automotive, ...